Abstract
TREATMENT of life-threatening bacterial infections in patients with severe neutropenia is extraordinarily difficult, at least as judged by any degree of long-term success. Although factors other than neutropenia often contribute to the susceptibility of such patients to infection, there is little doubt that neutropenia per se is associated with a marked increase in the frequency and severity of infection.1 Since replacement of platelets by transfusion has proved beneficial in preventing2 and treating3 bleeding in patients with thrombocytopenia, it is natural that interest has grown in the possible prevention and treatment of infection in patients with neutropenia by transfusing neutrophils. Although . . .